Folgen
Doreen Chan
Doreen Chan
Akero Therapeutics
Bestätigte E-Mail-Adresse bei akerotx.com
Titel
Zitiert von
Zitiert von
Jahr
Translational Applications of Hydrogels
S Correa, AK Grosskopf, H Lopez Hernandez, D Chan, AC Yu, ...
Chemical Reviews, 2021
4762021
A multiscale model for solute diffusion in hydrogels
E Axpe, D Chan, GS Offeddu, Y Chang, D Merida, HL Hernandez, ...
Macromolecules 52 (18), 6889-6897, 2019
1542019
Scalable manufacturing of biomimetic moldable hydrogels for industrial applications
AC Yu, H Chen, D Chan, G Agmon, LM Stapleton, AM Sevit, MW Tibbitt, ...
Proceedings of the National Academy of Sciences 113 (50), 14255-14260, 2016
822016
Combinatorial Polyacrylamide Hydrogels for Preventing Biofouling on Implantable Biosensors
EAA Doreen Chan, Jun-Chau Chien, Eneko Axpe, Louis Blankemeier, Samuel W ...
Advanced Materials, 2022
682022
Wildfire prevention through prophylactic treatment of high-risk landscapes using viscoelastic retardant fluids
AC Yu, H Lopez Hernandez, AH Kim, LM Stapleton, RJ Brand, ET Mellor, ...
Proceedings of the National Academy of Sciences 116 (42), 20820-20827, 2019
542019
A biocompatible therapeutic catheter‐deliverable hydrogel for in situ tissue engineering
AN Steele, LM Stapleton, JM Farry, HJ Lucian, MJ Paulsen, A Eskandari, ...
Advanced healthcare materials 8 (5), 1801147, 2019
502019
A co-formulation of supramolecularly stabilized insulin and pramlintide enhances mealtime glucagon suppression in diabetic pigs
EAA CL Maikawa, AAA Smith, L Zou, GA Roth, EC Gale, LM Stapleton, SW Baker ...
Nature Biomedical Engineering, 2020
462020
An ultrafast insulin formulation enabled by high-throughput screening of engineered polymeric excipients
JL Mann, CL Maikaway, AAA Smith, AK Grosskopf, SW Baker, RA Roth, ...
Science Translational Medicine 12 (550), 1-12, 2020
442020
A human mission to Mars: Predicting the bone mineral density loss of astronauts
E Axpe, D Chan, MF Abegaz, AS Schreurs, JS Alwood, RK Globus, ...
PLoS One 15 (1), e0226434, 2020
372020
Engineering the mechanical properties of polymer networks with precise doping of primary defects
D Chan, Y Ding, RH Dauskardt, EA Appel
ACS applied materials & interfaces 9 (48), 42217-42224, 2017
292017
More than a fertilizer: wastewater-derived struvite as a high value, sustainable fire retardant
AH Kim, CY Anthony, SH El Abbadi, K Lu, D Chan, EA Appel, CS Criddle
Green Chemistry 23 (12), 4510-4523, 2021
222021
Single-chain polymeric nanocarriers: a platform for determining structure–function correlations in the delivery of molecular cargo
D Chan, AC Yu, EA Appel
Biomacromolecules 18 (4), 1434-1439, 2017
192017
Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b …
SA Harrison, JP Frias, G Neff, GA Abrams, KJ Lucas, W Sanchez, S Gogia, ...
The Lancet Gastroenterology & Hepatology, 2023
172023
Full closed loop open‐source algorithm performance comparison in pigs with diabetes
RA Lal, CL Maikawa, D Lewis, SW Baker, AAA Smith, GA Roth, EC Gale, ...
Clinical and Translational Medicine 11 (4), 2021
112021
Polyacrylamide-based Hydrogel Coatings Improve Biocompatibility of Implanted Pump Devices
D Chan, CL Maikawa, AI d'Aquino, SS Raghavan, ML Troxell, EA Appel
Journal of Biomedical Materials Research Part A, 2023
62023
411 T. Zhang, PW Franzia, R. Langer, EA Appel, Scalable manufacturing of biomimetic moldable 412 hydrogels for industrial applications, P
AC Yu, H Chen, D Chan, G Agmon, LM Stapleton, AM Sevit, MW Tibbitt, ...
Natl. Acad. Sci 113, 14255-14260, 2016
62016
Angiogenic stem cell delivery platform to augment post-infarction neovasculature and reverse ventricular remodeling
HS Shin, A Thakore, Y Tada, AJ Pedroza, G Ikeda, IY Chen, D Chan, ...
Scientific Reports 12 (1), 17605, 2022
52022
Safety and Efficacy of Efruxifermin in Combination With a GLP-1 Receptor Agonist in Patients With NASH/MASH and Type 2 Diabetes in a Randomized Phase 2 Study
SA Harrison, JP Frias, KJ Lucas, G Reiss, G Neff, S Bollepalli, Y Su, ...
Clinical Gastroenterology and Hepatology, 2024
2024
Non-invasive tests of liver injury, inflammation and fibrosis are improved by efruxifermin and correlate with histological improvements in F2-F3 NASH patients: secondary …
J Schattenberg, JP Frias, G Neff, G Abrams, KJ Lucas, W Sanchez, ...
Journal of Hepatology 78, S808-S809, 2023
2023
Characterization of the patterns of resolution of histopathology after efruxifermin treatment of patients with NASH fibrosis (F2/3) for 24 weeks
C Behling, P Bedossa, L Shao, E Fong, B de Temple, D Chan, ...
Age (Years) 55 (57), 52, 2023
2023
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20